Trial Underway for Vaccine-Immunotherapy Combo in Bladder Cancer 🔗 Access full article via CureTodayA phase 1 trial just launched, and will evaluate IO102-IO103 plus Keytruda in patients with bladder cancer whose disease is unresponsive to BCG therapy. Share:TwitterFacebookEmailRedditMoreLinkedInWhatsAppTelegramMastodon
